Skip to main content

Alsuma FDA Approval History

FDA Approved: Yes (Discontinued) (First approved June 29, 2010)
Brand name: Alsuma
Generic name: sumatriptan
Dosage form: Injection
Company: King Pharmaceuticals, Inc.
Treatment for: Migraine, Cluster Headaches

Marketing Status: Discontinued

Alsuma (sumatriptan injection) is a triptan indicated for the acute treatment of migraine attacks and cluster headache episodes.

Development timeline for Alsuma

Jul  7, 2010Approval FDA Approves Alsuma Auto-Injector

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.